Monash IVF Group Limited
MNIVF
$0.40
-$0.11-21.57%
OTC PK
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Revenue | 5.35% | 9.38% | 13.52% | 15.64% | 16.26% |
Total Other Revenue | -98.73% | -59.55% | -28.17% | -7.09% | 24.93% |
Total Revenue | 5.24% | 9.30% | 13.47% | 15.62% | 16.27% |
Cost of Revenue | 5.83% | 10.34% | 15.05% | 16.92% | 17.26% |
Gross Profit | 4.09% | 7.25% | 10.42% | 13.11% | 14.36% |
SG&A Expenses | 13.71% | 8.59% | 3.34% | 7.50% | 10.45% |
Depreciation & Amortization | 17.02% | 16.48% | 15.85% | 17.73% | 17.94% |
Other Operating Expenses | -99.64% | -18.20% | 873.82% | 948.49% | 1,013.97% |
Total Operating Expenses | -13.55% | 7.18% | 34.02% | 38.54% | 41.62% |
Operating Income | 1,022.46% | 37.39% | -90.73% | -101.00% | -113.23% |
Income Before Tax | 431.62% | 43.76% | -111.48% | -122.55% | -135.36% |
Income Tax Expenses | 318.26% | 94.06% | -126.34% | -141.46% | -158.92% |
Earnings from Continuing Operations | 520.53% | 32.31% | -106.02% | -115.69% | -126.92% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -13.53% | -132.12% | -2,203.20% | -751.25% | -348.11% |
Net Income | 474.01% | 28.81% | -109.20% | -118.65% | -129.66% |
EBIT | 1,022.46% | 37.39% | -90.73% | -101.00% | -113.23% |
EBITDA | 547.50% | 27.72% | -63.72% | -71.11% | -80.52% |
EPS Basic | 473.21% | 28.57% | -109.31% | -118.67% | -129.71% |
Normalized Basic EPS | 422.41% | 33.60% | -110.57% | -121.53% | -134.12% |
EPS Diluted | 456.90% | 26.21% | -111.27% | -120.26% | -130.93% |
Normalized Diluted EPS | 417.95% | 33.06% | -111.17% | -122.16% | -134.51% |
Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Average Diluted Shares Outstanding | 0.06% | -0.09% | -0.24% | -0.28% | -0.32% |
Dividend Per Share | -47.56% | -16.35% | 17.45% | 15.25% | 11.19% |
Payout Ratio | 1.29% | -0.15% | -13.27% | -6.86% | -4.51% |